Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1600
-0.0056 (-3.38%)
At close: Jun 9, 2026, 4:00 PM EDT
0.1595
-0.0005 (-0.31%)
Pre-market: Jun 10, 2026, 4:49 AM EDT
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -87.97% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Gossamer Bio stock has a consensus rating of "Hold" and an average price target of $4.46. The average 1-year stock price forecast is 2,687.50% higher than the current stock price, while the lowest is $0.28 (+75.00%) and the highest is $15 (+9,275.00%).
Price Target: $4.46 (+2,687.50%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Gossamer Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 2 | 2 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 4 | 5 | 5 | 4 | 4 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +3,025.00% | Jun 1, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 19, 2026 |
| Wedbush | Wedbush | Hold Maintains $1 | Hold | Maintains | $1 | +525.00% | May 19, 2026 |
| Barclays | Barclays | Sell Maintains $0.3 → $0.28 | Sell | Maintains | $0.3 → $0.28 | +75.00% | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 20, 2026 |
Financial Forecast
Revenue This Year
36.44M
from 48.47M
Decreased by -24.83%
Revenue Next Year
53.00M
from 36.44M
Increased by 45.45%
EPS This Year
-0.46
from -0.75
EPS Next Year
-0.09
from -0.46
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 46.6M | ||
| Avg | 36.4M | ||
| Low | 22.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.9% | ||
| Avg | -24.8% | ||
| Low | -54.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.46 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |